Building a CAR-T CMC Strategy on a Limited Budget - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Building a CAR-T CMC Strategy on a Limited Budget

Early developers do not need a finalized commercial process before first-in-human studies, but they do need a clear plan for managing cost, scalability, comparability, and future manufacturing changes

  • By

  • Kate Fynes

  • October 6, 2026

  • 8 min

Share

Original Source(s)

Building a CAR-T CMC Strategy on a Limited Budget

  • by Kate Fynes

  • October 6, 2026

Related Content

Errors in Discussion and References

  • October 1, 2026

Authors’ Reply: Clarifying the Comparative Interpretation and Clinical Implications of Radiomics-Based AI for Pathological Response Prediction

Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation